Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Central-acting agents are also called as central adrenergic inhibitors, central alpha agonists and central agonists. Central-acting agents lower the heart rate and reduce the blood pressure. They work by preventing brain from sending signals to the nervous system to speed up the heart rate and narrow the blood vessels. As a result, heart doesnt pump as hard and blood flows more easily through the blood vessels. Clonidine, Guanfacine and Methyldopa are the examples of central-acting agents.
Central-acting agents used to prevent, treat or improve symptoms in conditions, such as:
• Attention-deficit/hyperactivity disorder (ADHD)
• Hot flashes
• Drug withdrawal
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Central-acting agents, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for Central-acting agents will appear here as matching content is published in Neurophysiology and Rehabilitation (ISSN: 2641-8991). Readers can also browse the journal archive and current issue for connected research.
